Search Results 161-170 of 18156 for crohns disease

1. Discovery's Edge: Hope For Healing With Regenerative Medicine - Mayo Clinic News Network

   Crohn's disease is chronic and has no known cure. It afflicts up to 700,000 Americans, according to the Crohn's and Colitis Foundation of America. Often ...

2. Advanced Inflammatory Bowel Disease Fellowship (Florida) - Residencies and Fellowships - Mayo Clinic College of Medicine & Science

   The Inflammatory Bowel Disease (IBD) Fellowship at Mayo Clinic in Jacksonville, Florida, is a 12-month program that offers intensive training in clinical ...

3. A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease - Mayo Clinic

   ... Crohn's Disease. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns.

4. Vedolizumab IV 300 mg in the Treatment of Fistulizing Crohn's Disease - Mayo Clinic

   ... Crohn's disease (CD). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...

5. A Study Comparing the Long Term Safety of Entyvio (Vedolizumab) to Other Biologic Agents in Patients with Ulcerative Colitis or Crohn's Disease - Mayo Clinic

   ... Crohn's Disease. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns.

6. Michael C. Stephens, M.D. - Doctors and Medical Staff - Mayo Clinic

   2017. Uniting Cure and Care AwardCrohn's and Colitis Foundation of America · 2016. International Lifetime Achievement AwardPediatric Gastroenterology, ...

7. Stem Cell Coated Fistula Plug in Patients With Crohn's RVF - Mayo Clinic

   ... Crohn's disease. Autologous means that these cells that coat the plug come from you. You will be in this study for two years. There is potential to continue ...

8. Open Label Study to Evaluate Long Term Efficacy, Safety and Tolerability of Repeated Dosing in Subjects with Crohn's Disease and Who Participated and Successfully Completed M14-115 - Mayo Clinic

   ... Crohn's Disease and Who Participated and Successfully Completed M14-115 ... Crohn's disease. Participation eligibility. Participant eligibility includes age ...

9. A Study to Evaluate Remicade (Infliximab) for the Prevention of Recurrence in Crohn's Disease Patients Undergoing Surgical Resection and are at an Increased Risk of Recurrence - Mayo Clinic

   ... Crohn's disease and may be useful in preventing a relapse of Crohn's disease after surgical resection. Participation eligibility. Participant eligibility ...

10. Publications - Michael C. Stephens, M.D. - Mayo Clinic

    Distinct cutoff values of adalimumab trough levels are associated with different therapeutic outcomes in patients with inflammatory bowel disease. Crohn's & ...